Dataset Information


High-level expression of the malaria blood-stage vaccine candidate Plasmodium falciparum apical membrane antigen 1 and induction of antibodies that inhibit erythrocyte invasion.

ABSTRACT: Apical membrane antigen 1 (AMA-1) is a highly promising malaria blood-stage vaccine candidate that has induced protection in rodent and nonhuman primate models of malaria. Authentic conformation of the protein appears to be essential for the induction of parasite-inhibitory antibody responses. Here we have developed a synthetic gene with adapted codon usage to allow expression of Plasmodium falciparum FVO strain AMA-1 (PfAMA-1) in Pichia pastoris. In addition, potential N-glycosylation sites were changed, exploiting the lack of conservation of these sites in Plasmodium, to obtain high-level secretion of a homogeneous product, suitable for scale-up according to current good manufacturing procedures. Purified PfAMA-1 displayed authentic antigenic properties, indicating that the amino acid changes had no deleterious effect on the conformation of the protein. High-titer antibodies, raised in rabbits, reacted strongly with homologous and heterologous P. falciparum by immunofluorescence. In addition, purified immunoglobulin G from immunized animals strongly inhibited invasion of red blood cells by homologous and, to a somewhat lesser extent, heterologous P. falciparum.


PROVIDER: S-EPMC128198 | BioStudies | 2002-01-01

REPOSITORIES: biostudies

Similar Datasets

2009-01-01 | S-EPMC2669163 | BioStudies
1000-01-01 | S-EPMC174223 | BioStudies
2005-01-01 | S-EPMC538964 | BioStudies
2016-01-01 | S-EPMC5006270 | BioStudies
2007-01-01 | S-EPMC1847697 | BioStudies
2010-01-01 | S-EPMC2850360 | BioStudies
2018-01-01 | S-EPMC5804060 | BioStudies
2019-01-01 | S-EPMC6664700 | BioStudies
2009-01-01 | S-EPMC2654807 | BioStudies
2019-01-01 | S-EPMC6751645 | BioStudies